Literature DB >> 4317384

Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity.

R D Collins, M H Weinberger, A J Dowdy, G W Nokes, C M Gonzales, J A Luetscher.   

Abstract

Among 25 patients with benign, essential hypertension, and an equal number with other benign forms of hypertension, without serious cardiac, renal, or cerebrovascular impairment, 41 cases failed to reduce aldosterone excretion rates into the normal range (less than 5 mug/day) on a daily intake of 300 mEq of sodium. The hypertensive patients excreted slightly less than the normal fraction of labeled aldosterone as acid-hydrolyzable conjugate. Secretion rates were significantly higher in the hypertensive patients than in normotensive controls taking the high-sodium intake. On a 10 mEq sodium intake, the increase in excretion and secretion rates of aldosterone in the hypertensive patients could be correlated with plasma renin activity (PRA). The patients with the least increase in PRA had subnormal increase in aldosterone secretion and excretion, while unusually large rises in aldosterone secretion accompanied high PRA, especially in the cases with increased plasma angiotensinogen induced by oral contraceptives. The persistence of inappropriately high aldosterone secretion in most hypertensive patients during sodium loading could be related to a higher PRA than that found in normotensive controls under comparable conditions. In other hypertensives, whose PRA was unresponsive to sodium depletion, there was no significant correlation between PRA and aldosterone output, and no known stimulus to aldosterone production was detected. Five obvious cases of hyperaldosteronism were found among the 16 low-renin patients. The cause of the nonsuppressible aldosterone production in the other low-renin cases remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4317384      PMCID: PMC322615          DOI: 10.1172/JCI106359

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Primary aldosteronism with unusual secretory pattern.

Authors:  E G Biglieri; P E Slaton; S J Kronfield; J B Deck
Journal:  J Clin Endocrinol Metab       Date:  1967-05       Impact factor: 5.958

2.  Improvement in methodology for measurement of plasma renin activity.

Authors:  R Boucher; J Genest
Journal:  Can J Physiol Pharmacol       Date:  1966-01       Impact factor: 2.273

Review 3.  Mechanisms regulating adrenocortical secretion of aldosterone and glucocorticoids.

Authors:  W F Ganong; E G Biglieri; P J Mulrow
Journal:  Recent Prog Horm Res       Date:  1966

Review 4.  Aldosteronism and hypertension.

Authors:  J O Davis
Journal:  Prog Cardiovasc Dis       Date:  1965-09       Impact factor: 8.194

5.  Incidence of primary aldosteronism uncomplicated "essential" hypertension. A prospective study with elevated aldosterone secretion and suppressed plasma renin activity used as diagnostic criteria.

Authors:  L M Fishman; O Küchel; G W Liddle; A M Michelakis; R D Gordon; W T Chick
Journal:  JAMA       Date:  1968-08-12       Impact factor: 56.272

6.  Plasma renin activity and aldosterone secretion in hypertensive patients during high and low sodium intake and administration of diuretic.

Authors:  M H Weinberger; A J Dowdy; G W Nokes; J A Luetscher
Journal:  J Clin Endocrinol Metab       Date:  1968-03       Impact factor: 5.958

7.  Aldosterone excretion in normal children and in children with adrenal hyperplasia.

Authors:  M I New; B Miller; R E Peterson
Journal:  J Clin Invest       Date:  1966-03       Impact factor: 14.808

8.  Postural augmentation of plasma renin activity and aldosterone excretion in normal people.

Authors:  E L Cohen; J W Conn; D R Rovner
Journal:  J Clin Invest       Date:  1967-03       Impact factor: 14.808

9.  Relation between potassium balance and aldosterone secretion in normal subjects and in patients with hypertensive or renal tubular disease.

Authors:  P J Cannon; R P Ames; J H Laragh
Journal:  J Clin Invest       Date:  1966-06       Impact factor: 14.808

10.  Oral contraceptives. Renin, aldosterone, and high blood pressure.

Authors:  J H Laragh; J E Sealey; J G Ledingham; M A Newton
Journal:  JAMA       Date:  1967-09-18       Impact factor: 56.272

View more
  25 in total

1.  [Plasma aldosterone and plasma renin activity in patients with essential and renal hypertension under acute stimulation with saline depletion and acute suppression with saline infusion].

Authors:  F Klumpp; D Klaus; R Lemke; J Zehner; P Zöfel
Journal:  Klin Wochenschr       Date:  1975-03-01

2.  Jeremiah Metzger lecture, 1974: The renin-angiotensin system. Some new aspects.

Authors:  J Genest; R Boucher; O Kuchel; J M Rojo-Ortega; W Nowaczynski
Journal:  Trans Am Clin Climatol Assoc       Date:  1975

Review 3.  Primary aldosteronism.

Authors:  R D Gordon
Journal:  J Endocrinol Invest       Date:  1995 Jul-Aug       Impact factor: 4.256

4.  The adrenal receptor for angiotensin II is altered in essential hypertension.

Authors:  G H Williams; N K Hollenberg; T J Moore; S L Swartz; R G Dluhy
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

5.  The atrial natriuretic factor in mild essential hypertension.

Authors:  J Genest; P Larochelle; J R Cusson; J Gutkowska; M Cantin; R Garcia; G Thibault; O Kuchel; A De Léan; P Hamet
Journal:  Trans Am Clin Climatol Assoc       Date:  1987

Review 6.  The atrial natriuretic factor.

Authors:  J Genest
Journal:  Br Heart J       Date:  1986-10

7.  [Suppression and stimulation of plasma renin concentration in primary hyper-aldosteronism].

Authors:  R Beckerhoff; R Wilkinson; J A Luetscher; W Vetter; W Siegenthaler
Journal:  Klin Wochenschr       Date:  1972-08-15

8.  [Aldosterone excretion and plasma renin activity in patients with essential hypertension and with primary aldosteronism (author's transl)].

Authors:  A Helber; K A Meurer; E Rosskamp; G Wambach; H A Dickmans; W Kaufmann
Journal:  Klin Wochenschr       Date:  1974-10-15

9.  Studies of the control of plasma aldosterone concentration in normal man. 3. Response to sodium chloride infusion.

Authors:  G H Williams; M L Tuck; L I Rose; R G Dluhy; R H Underwood
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

Review 10.  Role of the adrenal cortex and sodium in the pathogenesis of human hypertension.

Authors:  J Genest; W Nowaczynski; R Boucher; O Kuchel
Journal:  Can Med Assoc J       Date:  1978-03-04       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.